{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:33:48Z","timestamp":1789612428998,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,21]],"date-time":"2027-01-21T00:00:00Z","timestamp":1800489600000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.prp.2026.156373","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:23:19Z","timestamp":1768807399000},"page":"156373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of CCL22 and its histamine-associated modulation in the tumor microenvironment of tongue squamous cell carcinoma"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5038-9064","authenticated-orcid":false,"given":"Satoshi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Shimajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156373_bib1","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer","volume":"18","author":"Mody","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2026.156373_bib2","doi-asserted-by":"crossref","first-page":"C1611","DOI":"10.1152\/ajpcell.00098.2022","article-title":"Squamous cell carcinoma of the tongue: subtypes and morphological features affecting prognosis","volume":"323","author":"Matsuo","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.prp.2026.156373_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.oraloncology.2010.11.003","article-title":"Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors","volume":"47","author":"Bachar","year":"2011","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.prp.2026.156373_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1748-717X-1-21","article-title":"Brachytherapy of stage II mobile tongue carcinoma: prediction of local control and QOL","volume":"1","author":"Oota","year":"2006","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.prp.2026.156373_bib5","first-page":"e579","article-title":"Clinicopathological evaluation and survival of patients with squamous cell carcinoma of the tongue","volume":"23","author":"N\u00f3brega","year":"2018","journal-title":"Med. Oral. Patol. Oral. Cir. Bucal"},{"key":"10.1016\/j.prp.2026.156373_bib6","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2026.156373_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hed.23380","article-title":"Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer","volume":"36","author":"Almangush","year":"2014","journal-title":"Head. Neck"},{"key":"10.1016\/j.prp.2026.156373_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1600-0714.2011.01041.x","article-title":"Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma","volume":"40","author":"Wang","year":"2011","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.prp.2026.156373_bib9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/his.13790","article-title":"A novel prognostic model for tongue squamous cell carcinoma based on the characteristics of tumour and its microenvironment: iBD score","volume":"74","author":"Yu","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2026.156373_bib10","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1739\/aa7e86","article-title":"Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression","volume":"3","author":"Seager","year":"2017","journal-title":"Converg. Sci. Phys. Oncol."},{"key":"10.1016\/j.prp.2026.156373_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/biom14040438","article-title":"The Tumor Microenvironment: Signal Transduction","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2026.156373_bib12","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1038\/s41467-023-41518-w","article-title":"The tumor microenvironment shows a hierarchy of cell-cell interactions dominated by fibroblasts","volume":"14","author":"Mayer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2026.156373_bib13","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.4049\/jimmunol.172.12.7761","article-title":"Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxis","volume":"172","author":"Cronshaw","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9440(10)64077-1","article-title":"Macrophage-derived chemokine (MDC\/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue","volume":"158","author":"Katou","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2026.156373_bib15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2026.156373_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000764","article-title":"Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4","volume":"8","author":"Marshall","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2026.156373_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jop.12885","article-title":"Macrophage CCL22 expression in the tumor microenvironment and implications for survival in patients with squamous cell carcinoma of the tongue","volume":"48","author":"Kimura","year":"2019","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.prp.2026.156373_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/ol.2021.12644","article-title":"Macrophage CCL22 expression promotes lymphangiogenesis in patients with tongue squamous cell carcinoma via IL-4\/STAT6 in the tumor microenvironment","volume":"21","author":"Kimura","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2026.156373_bib19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/biom11081232","article-title":"Pathophysiological roles of histamine receptors in cancer progression: implications and perspectives as potential molecular targets","volume":"11","author":"Nguyen","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2026.156373_bib20","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1172\/JCI200113930","article-title":"Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization","volume":"108","author":"Mazzoni","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2026.156373_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bph.14535","article-title":"Histamine receptors and cancer pharmacology: an update","volume":"177","author":"Massari","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.prp.2026.156373_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","article-title":"The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2026.156373_bib23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/odi.13411","article-title":"Nothing to sneeze at: histamine and histamine receptors in oral carcinogenesis","volume":"27","author":"Salem","year":"2021","journal-title":"Oral. Dis."},{"key":"10.1016\/j.prp.2026.156373_bib24","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/hed.27056","article-title":"Relationship of histamine expression with chemokine balance in the tumor microenvironment of squamous cell carcinoma of the tongue","volume":"44","author":"Kimura","year":"2022","journal-title":"Head. Neck"},{"key":"10.1016\/j.prp.2026.156373_bib25","first-page":"61","article-title":"High histamine expression by early-stage squamous cell carcinoma of the tongue is associated with a poor prognosis","volume":"41","author":"Kimura","year":"2026","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.prp.2026.156373_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2026.156373_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2026.156373_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106458","article-title":"Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence","volume":"143","author":"Daroonpan","year":"2023","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.prp.2026.156373_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3892\/ol.2013.1238","article-title":"Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1 surface expression","volume":"5","author":"Lu","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2026.156373_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/pathogens13010093","article-title":"The Roles and Interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in Oral and Gastrointestinal Carcinogenesis: A Narrative Review","volume":"13","author":"Wang","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.prp.2026.156373_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100813","article-title":"Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)","volume":"31","author":"Michikawa","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.prp.2026.156373_bib32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijom.2019.04.004","article-title":"Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma","volume":"48","author":"Kouketsu","year":"2019","journal-title":"Int. J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.prp.2026.156373_bib33","first-page":"2187","article-title":"Analysis of Treg\/Th17 cells in patients with tongue squamous cell carcinoma","volume":"18","author":"Liu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.prp.2026.156373_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5715719","article-title":"Immunosuppression induced by chronic inflammation and the progression to oral squamous cell carcinoma","volume":"2016","author":"Sun","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.prp.2026.156373_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.oraloncology.2012.09.012","article-title":"Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma","volume":"49","author":"Costa","year":"2013","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.prp.2026.156373_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1485174","article-title":"Tumor microenvironment in oral squamous cell carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2019.151446","article-title":"Cancer-associated fibroblasts in the tumor microenvironment of tongue carcinoma is a heterogeneous cell population","volume":"121","author":"Vered","year":"2019","journal-title":"Acta Histochem"},{"key":"10.1016\/j.prp.2026.156373_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3892\/ol.2010.201","article-title":"Phenotype of tumor lymphatic vessels is a prognostic factor in human tongue squamous cell carcinoma","volume":"2","author":"Nitta","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2026.156373_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1199225","article-title":"Tumour associated endothelial cells, origin, characteristics and role in metastasis and anti-angiogenic resistance","volume":"14","author":"Yao","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.prp.2026.156373_bib40","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1158\/1078-0432.CCR-03-0670","article-title":"Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression","volume":"10","author":"L\u00f3pez de Cicco","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2026.156373_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4103\/jomfp.jomfp_134_23","article-title":"Tumour microenvironment as a potential immune therapeutic target for tongue cancer management","volume":"27","author":"Janardhanan","year":"2023","journal-title":"J. Oral. Maxillofac. Pathol."},{"key":"10.1016\/j.prp.2026.156373_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00428-020-02930-5","article-title":"Stromal categorization in early oral tongue cancer","volume":"478","author":"Almangush","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2026.156373_bib43","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1186\/s12885-024-13317-z","article-title":"Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection","volume":"24","author":"Almangush","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2026.156373_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.622161","article-title":"Increased tumor immune microenvironment CD3+ and CD20+ lymphocytes predict a better prognosis in oral tongue squamous cell carcinoma","volume":"8","author":"Sales de S\u00e1","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2026.156373_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1287650","article-title":"Enhancing oral squamous cell carcinoma prediction: the prognostic power of the worst pattern of invasion and the limited impact of molecular resection margins","volume":"13","author":"Hurn\u00edk","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156373_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12935-024-03518-8","article-title":"The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis","volume":"24","author":"Yu","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.prp.2026.156373_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195451","article-title":"Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma, with special reference to the mode of invasion and worst pattern of invasion","volume":"13","author":"Shimizu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2026.156373_bib48","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1038\/s41467-022-32787-y","article-title":"OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling","volume":"13","author":"Ding","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2026.156373_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2026.156373_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2026.156373_bib51","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jcp.24816","article-title":"IL-1\u03b2 promotes malignant transformation and tumor aggressiveness in oral cancer","volume":"230","author":"Lee","year":"2015","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.prp.2026.156373_bib52","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.3390\/ijms21207619","article-title":"CC Chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156373_bib53","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.3390\/ijms21218412","article-title":"CC Chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156373_bib54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s12967-025-06707-9","article-title":"CXCR4\/CXCL12 axis promotes lymphatic metastasis in tongue squamous cell carcinoma via PI3K\/AKT signaling pathway","volume":"23","author":"Lou","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.prp.2026.156373_bib55","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1440-1827.2012.02854.x","article-title":"Expression of macrophage-derived chemokine (CCL22) in atherosclerosis and regulation by histamine via the H2 receptor","volume":"62","author":"Kimura","year":"2012","journal-title":"Pathol. Int"},{"key":"10.1016\/j.prp.2026.156373_bib56","series-title":"Gene ID: 6367, CCL22 C-C motif chemokine ligand 22 [Internet]","author":"National Center for Biotechnology Information (NCBI)","year":"2025"},{"key":"10.1016\/j.prp.2026.156373_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/imm.12596","article-title":"Critical role of CCL22\/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8\u03b1(+) CD103(+) dendritic cells","volume":"148","author":"Hao","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.prp.2026.156373_bib58","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-08-2360","article-title":"Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156373_bib59","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/cancers12061411","article-title":"Transcriptional, epigenetic and metabolic programming of tumor-associated macrophages","volume":"12","author":"Larionova","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156373_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biom15010071","article-title":"Epigenetic regulation of stromal and immune cells and therapeutic targets in the tumor microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2026.156373_bib61","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.2174\/0109298673309489240816063313","article-title":"The investigation of Nf\u03bab inhibitors to block cell proliferation in OSCC cell lines","volume":"32","author":"Cheng","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prp.2026.156373_bib62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-030-36667-4_8","article-title":"CCL22 signaling in the tumor environment","volume":"1231","author":"R\u00f6hrle","year":"2020","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.prp.2026.156373_bib63","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2026.156373_bib64","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.3390\/cancers13215542","article-title":"CCR4 as a therapeutic target for cancer immunotherapy","volume":"13","author":"Yoshie","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156373_bib65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.celrep.2017.06.079","article-title":"An atlas of human regulatory T helper-like cells reveals features of Th2-like Tregs that support a tumorigenic environment","volume":"20","author":"Halim","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2026.156373_bib66","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.20041059","article-title":"A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations","volume":"201","author":"Baekkevold","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2026.156373_bib67","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.4049\/jimmunol.0801124","article-title":"NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment","volume":"182","author":"Mailloux","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib68","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/ijc.23392","article-title":"CCL17 and CCL22chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer","volume":"122","author":"Mizukami","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2026.156373_bib69","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","article-title":"T-regulatory cells: key players in tumor immune escape and angiogenesis","volume":"72","author":"Facciabene","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156373_bib70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/vaccines4030028","article-title":"Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting","volume":"4","author":"Chaudhary","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.prp.2026.156373_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1328193","article-title":"Mechanisms underlying immunosuppression by regulatory cells","volume":"15","author":"Goldmann","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41419-025-07544-w","article-title":"Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application","volume":"16","author":"Pan","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2026.156373_bib73","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156373_bib74","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/cancers13081850","article-title":"Recruitment and expansion of Tregs cells in the tumor environment-how to target them?","volume":"13","author":"Cinier","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156373_bib75","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156373_bib76","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cancers13020210","article-title":"The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment","volume":"13","author":"Haist","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156373_bib77","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1175794","article-title":"Cancer cell-derived IL-1\u03b1 induces CCL22 and the recruitment of regulatory T cells","volume":"5","author":"Wiedemann","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.prp.2026.156373_bib78","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/pros.23194","article-title":"Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells","volume":"76","author":"Muthuswamy","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.prp.2026.156373_bib79","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12105-020-01229-w","article-title":"Transcriptomic and immunophenotypic characterization of tumor immune microenvironment in squamous cell carcinoma of the oral tongue","volume":"15","author":"Chatzopoulos","year":"2021","journal-title":"Head. Neck Pathol."},{"key":"10.1016\/j.prp.2026.156373_bib80","article-title":"Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib81","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/cas.14135","article-title":"Cancer-associated fibroblast-derived interleukin-1\u03b2 activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer","volume":"110","author":"Huang","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2026.156373_bib82","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1158\/0008-5472.CAN-16-0618","article-title":"Ccl22 diverts T regulatory cells and controls the growth of melanoma","volume":"76","author":"Klarquist","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2026.156373_bib83","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.crimmu.2021.08.002","article-title":"Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape","volume":"2","author":"Sarkar","year":"2021","journal-title":"Curr. Res. Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104738","article-title":"Diagnostic, prognostic, and metastatic value of chemokines as biomarkers for oral squamous cell carcinoma and their precursor lesions - a systematic review","volume":"211","author":"Braun","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.prp.2026.156373_bib85","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ajpath.2019.12.007","article-title":"Diminished CD68+ cancer-associated fibroblast subset induces regulatory T-cell (Treg) infiltration and predicts poor prognosis of oral squamous cell carcinoma patients","volume":"190","author":"Zhao","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2026.156373_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2022.100896","article-title":"The CC ligand chemokine family members CCL17\/CCL22 predict the survival and response to immune checkpoint blockade therapy of patients with head and neck squamous cell carcinoma","volume":"46","author":"Zhou","year":"2022","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.prp.2026.156373_bib87","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hed.23217","article-title":"Focus on the role of the CXCL12\/CXCR4 chemokine axis in head and neck squamous cell carcinoma","volume":"35","author":"Albert","year":"2013","journal-title":"Head. Neck"},{"key":"10.1016\/j.prp.2026.156373_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108198","article-title":"Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma","volume":"171","author":"Gong H","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.prp.2026.156373_bib89","article-title":"An immune-related gene signature can predict clinical outcomes and immunotherapeutic response in oral squamous cell carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Genet"},{"key":"10.1016\/j.prp.2026.156373_bib90","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.3390\/ijms24043317","article-title":"Identification and biological validation of a chemokine\/chemokine receptor-based risk model for predicting immunotherapeutic response and prognosis in head and neck squamous cell carcinoma","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156373_bib91","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/ijms20020376","article-title":"Expression of histidine decarboxylase and its roles in inflammation","volume":"20","author":"Hirasawa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156373_bib92","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/gtc.12774","article-title":"Histamine and histidine decarboxylase: Immunomodulatory functions and regulatory mechanisms","volume":"25","author":"Moriguchi","year":"2020","journal-title":"Genes Cells"},{"key":"10.1016\/j.prp.2026.156373_bib93","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.job.2022.01.003","article-title":"Epigallocatechin gallate stimulated histamine production and downregulated histamine H1 receptor in oral cancer cell lines expressing histidine decarboxylase","volume":"64","author":"Kon","year":"2022","journal-title":"J. Oral. Biosci."},{"key":"10.1016\/j.prp.2026.156373_bib94","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5551\/jat.27417","article-title":"CCL22\/macrophage-derived chemokine expression in apolipoprotein E-deficient mice and effects of histamine in the setting of atherosclerosis","volume":"22","author":"Kimura","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.prp.2026.156373_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.778","article-title":"Histamine in cancer immunology and immunotherapy. Current status and new perspectives","volume":"9","author":"Sarasola","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.prp.2026.156373_bib96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1471-4906(02)02215-9","article-title":"Trends in histamine research: new functions during immune responses and hematopoiesis","volume":"23","author":"Schneider","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib97","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2567.2006.02326.x","article-title":"Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells","volume":"117","author":"McIlroy","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.prp.2026.156373_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103016","article-title":"M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages","volume":"69","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.prp.2026.156373_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.378","article-title":"Histamine: a potential cytoprotective agent to improve cancer therapy?","volume":"6","author":"Martinel Lamas","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2026.156373_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22773-1","article-title":"Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma","volume":"12","author":"Ono","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156373_bib101","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010634","article-title":"Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors","volume":"13","author":"Jinushi","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2026.156373_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121306","article-title":"Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer","volume":"280","author":"Zhou","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.prp.2026.156373_bib103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2026.156373_bib104","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41423-022-00903-z","article-title":"Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)","volume":"19","author":"Chen","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: from bench to bedside","volume":"27","author":"Yoshie","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.prp.2026.156373_bib106","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1021\/acsmedchemlett.8b00351","article-title":"CCR4 antagonists inhibit Treg trafficking into the tumor microenvironment","volume":"9","author":"Ketcham","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.prp.2026.156373_bib107","doi-asserted-by":"crossref","first-page":"15638","DOI":"10.3390\/ijms232415638","article-title":"CC chemokine receptor 4 (CCR4) as a possible new target for therapy","volume":"23","author":"Bogacka","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156373_bib108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12935-023-02943-5","article-title":"Targeting oral tumor microenvironment for effective therapy","volume":"23","author":"Budi","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.prp.2026.156373_bib109","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","article-title":"Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response","volume":"14","author":"Arora","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2026.156373_bib110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41368-023-00267-8","article-title":"Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma","volume":"16","author":"Liu","year":"2024","journal-title":"Int. J. Oral. Sci."},{"key":"10.1016\/j.prp.2026.156373_bib111","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12929-022-00879-y","article-title":"Spatial multi-omics analyses of the tumor immune microenvironment","volume":"29","author":"Hsieh","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.prp.2026.156373_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.914120","article-title":"Single-cell transcriptome analysis reveals changes of tumor immune microenvironment in oral squamous cell carcinoma after chemotherapy","volume":"10","author":"Song","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2026.156373_bib113","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/bioinformatics\/btac122","article-title":"SEPA: signaling entropy-based algorithm to evaluate personalized pathway activation for survival analysis on pan-cancer data","volume":"38","author":"Li","year":"2022","journal-title":"Bioinformatics"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:55:35Z","timestamp":1770220535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":113,"alternative-id":["S0344033826000245"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156373","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of CCL22 and its histamine-associated modulation in the tumor microenvironment of tongue squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156373"}}